By Matthew Perlman ( March 30, 2017, 6:04 PM EDT) -- GlaxoSmithKline PLC urged the Third Circuit on Wednesday not to consider its recent ruling in a product liability case over the drug Fosamax when deciding whether or not to revive a pay-for-delay suit brought by buyers of Wellbutrin, saying that the cases differ in a number of ways....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.